AKTX

Akari Therapeutics
AKTX

Overview Fund Activity

14 hedge funds and large institutions have $394K invested in Akari Therapeutics in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PAI
1
Palo Alto Investors
California
$178K
2
CCG
2
Catalina Capital Group
California
$16K
3
ACM
3
Accent Capital Management
Ohio
$12.2K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$28.6K
5
UBS Group
5
UBS Group
Switzerland
$237

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$7
Name Market Value Shares Shares
Change 		Shares
Change %
PAI
1
Palo Alto Investors
California
$178K 146,024 +146,024 New
OFW
2
Omnia Family Wealth
Florida
$107K 87,628 – –
Cerity Partners
3
Cerity Partners
New York
$28.8K 23,643 – –
Renaissance Technologies
4
Renaissance Technologies
New York
$28.6K 23,465 +5,396 +30%
CAM
5
Cresset Asset Management
Illinois
$22.5K 18,408 – –
CCG
6
Catalina Capital Group
California
$16K 13,105 +13,105 New
ACM
7
Accent Capital Management
Ohio
$12.2K 10,000 +10,000 New
UBS Group
8
UBS Group
Switzerland
$237 194 +194 New
Bank of America
9
Bank of America
North Carolina
$183 150 – –
Osaic Holdings
10
Osaic Holdings
Arizona
$122 100 – –
TC
11
Truvestments Capital
Florida
$61 50 – –
Morgan Stanley
12
Morgan Stanley
New York
$7 6 -2 -25%
CPG
13
Cornerstone Planning Group
New Jersey
$6 5 – –
SS
14
SBI Securities
Japan
$6 5 +5 New
Citadel Advisors
15
Citadel Advisors
Florida
– – -33,260 Closed
CFGS
16
Concourse Financial Group Securities
Alabama
– – – –